Thesis DrivenOperator Database

It's how Vendors sell into real estate.

Catalyst signals + product updates. No spam, unsubscribe anytime.

Product
  • Database
  • Signals
  • Directory
  • Investment Themes
  • Markets
  • Operator Types
Company
  • Overview
  • Pricing
Account
  • Sitemap (XML)
© 2023–2026 Thesis Driven. All rights reserved.
TermsPrivacy
Thesis DrivenOperator Database
DashboardSignalsOnboarding
  1. Database
  2. /
  3. Investment Themes
  4. /
  5. Life Science

Office & Commercial

Life Science

Life Science illustration

Life science real estate development in the United States is a rapidly growing segment, driven by burgeoning demand from biotech firms, pharmaceutical companies, and research institutions. As of 2023, the U.S. life science real estate market was valued at around $35 billion, with a compound annual growth rate of approximately 10%. This surge is fueled by increased investment in biomedical research, an aging population requiring more healthcare services, and the continuous evolution of biotechnology.

Key markets for life science real estate include Boston, San Francisco, and San Diego, known for their robust ecosystems of research universities, hospitals, and biotech startups. These areas offer a unique blend of talent, technology, and capital, making them attractive for both developers and tenants. Boston, for example, has over 30 million square feet of lab space, underscoring its position as a leading hub in this sector.

The design and construction of life science facilities are highly specialized, requiring advanced ventilation systems, clean rooms, and adaptable lab spaces. The capital expenditure per square foot for life science buildings is significantly higher than traditional office spaces, often exceeding 50-60%. This reflects the complex infrastructure and stringent regulatory requirements essential for research and development activities.

Investors and developers are increasingly recognizing the resilience and long-term potential of the life science real estate market. Institutional investors, such as pension funds and REITs, are actively expanding their portfolios in this sector. The robust demand for life science facilities, coupled with the limited supply of suitable spaces, has led to low vacancy rates, typically below 5% in top markets, and robust rent growth, further solidifying its attractiveness as an investment class. The convergence of scientific innovation and real estate development in this field is poised to continue shaping the landscape of the U.S. real estate market.

Developers building in Life Science

315 in the database
Singerman Real Estate
Singerman Real Estate
980 N Michigan Avenue Suite 1700 Chicago, IL
Singerman Real Estate cover image
Employees—
Principals6
Markets8
Last updated: Nov 13, 2026
Affinius Capital
Affinius Capital
TX 78230, USA
Affinius Capital cover image
Employees201–500
Principals14
Markets9
Last updated: Nov 13, 2026
Altus Realty
Altus Realty
VA 22209, USA
Altus Realty cover image
Employees2–10
Principals3
Markets1
Last updated: Nov 13, 2026
CRG
CRG
MO 63134, USA
CRG cover image
Employees51–200
Principals24
Markets13
Last updated: Nov 13, 2026
Alexandria Real Estate Equities, Inc.
Alexandria Real Estate Equities, Inc.
CA, United States
Alexandria Real Estate Equities, Inc. cover image
Employees501–1,000
Principals12
Markets7
Last updated: Nov 13, 2026
BXP, Inc.
BXP, Inc.
MA 02199, USA
BXP, Inc. cover image
Employees501–1,000
Principals56
Markets5
Last updated: Nov 13, 2026
View all 315 developers in Life Science

Top markets for Life Science

  • California· 150
  • Massachusetts· 102
  • Texas· 91
  • New York· 79
  • North Carolina· 72
  • District of Columbia· 67
  • Florida· 66
  • Illinois· 61

Typical unlevered yield on cost

5.0 - 7.0%

Looking for developers active in Life Science? Search and filter the full Operator Database.

Search the database